Back
Bicara Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
49
BCAX
Bicara Therapeutics, Inc.
Last Price:
$21.43
Seasonality Move:
-23.95%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BCAX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Bicara Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.38 | Buy |
| 20-day SMA: | 19.21 | Buy |
| 50-day SMA: | 17.43 | Buy |
| 200-day SMA: | 14.92 | Buy |
| 8-day EMA: | 19.79 | Buy |
| 20-day EMA: | 19.02 | Buy |
| 50-day EMA: | 18.03 | Buy |
| 200-day EMA: | 16.37 | Buy |
Bicara Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.73 | Buy |
| Relative Strength Index (14 RSI): | 71.54 | Buy |
| Chaikin Money Flow: | 884845 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.98 - 19.9) | Buy |
| Bollinger Bands (100): | (15.65 - 18.89) | Buy |
Bicara Therapeutics, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Bicara Therapeutics, Inc. Stock
Is Bicara Therapeutics, Inc. Stock a Buy?
-
Bicara Therapeutics, Inc. share price is 21.47 while BCAX 8-day simple moving average is 19.38, which is a Buy signal.
-
The stock price of BCAX is 21.47 while Bicara Therapeutics, Inc. 20-day SMA is 19.21, which makes it a Buy.
-
Bicara Therapeutics, Inc. 50-day simple moving average is 17.43 while BCAX share price is 21.47, making it a Buy technically.
-
BCAX stock price is 21.47 and Bicara Therapeutics, Inc. 200-day simple moving average is 14.92, creating a Buy signal.
BCAX Technical Analysis vs Fundamental Analysis
Sell
49
Bicara Therapeutics, Inc. (BCAX)
is a Sell
Is Bicara Therapeutics, Inc. a Buy or a Sell?
-
Bicara Therapeutics, Inc. stock is rated a SellThe current Bicara Therapeutics, Inc. [BCAX] share price is $21.47. The Score for BCAX is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
Bicara Therapeutics, Inc. Stock Info
Market Cap:
1.5B
Price in USD:
21.47
Share Volume:
919.8K
Bicara Therapeutics, Inc. 52-Week Range
52-Week High:
21.50
52-Week Low:
7.80
Sell
49
Bicara Therapeutics, Inc. (BCAX)
is a Sell
Bicara Therapeutics, Inc. Share Price Forecast
-
What is the Bicara Therapeutics, Inc. stock price today?The Bicara Therapeutics, Inc. stock price is 21.47 USD today.
-
Will BCAX stock go up or go down?Bicara Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Bicara Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Bicara Therapeutics, Inc. is overvalued.
Is Bicara Therapeutics, Inc. Stock a Buy?
-
Bicara Therapeutics, Inc. share price is 21.47 while BCAX 8-day exponential moving average is 19.79, which is a Buy signal.
-
The stock price of BCAX is 21.47 while Bicara Therapeutics, Inc. 20-day EMA is 19.02, which makes it a Buy.
-
Bicara Therapeutics, Inc. 50-day exponential moving average is 18.03 while BCAX share price is 21.47, making it a Buy technically.
-
BCAX stock price is 21.47 and Bicara Therapeutics, Inc. 200-day simple moving average is 16.37, creating a Buy signal.
Fundamental Analysis of Bicara Therapeutics, Inc.
Is Bicara Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.31 per share, and a decrease next year of $0.25 per share.
Technical Analysis of Bicara Therapeutics, Inc.
Should I short Bicara Therapeutics, Inc. stock?
-
BCAX Moving Average Covergence Divergence (MACD) indicator is 0.73, suggesting Bicara Therapeutics, Inc. is a Buy
-
Bicara Therapeutics, Inc. Relative Strength Index (RSI) is 71.54, which suggest Bicara Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Bicara Therapeutics, Inc. is (17.98 - 19.9), which suggest Bicara Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Bicara Therapeutics, Inc. is (15.65 - 18.89), which suggest Bicara Therapeutics, Inc. is a Buy
* Bicara Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.